Enhanced Group went public Friday at a $1.2 billion valuation, via a SPAC reverse merger, pitching investors on athletic competitions that permit performance enhancing drugs.
The intrigue: Advertisers drive sports events businesses, but they've pulled back from high-profile athletes involved in doping scandals.
